• Explore /
  • Poster
  • / A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX (mFOLFIRINOX) in previously untreated patients (pts) with advanced gastrointestinal malignancies.

A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX (mFOLFIRINOX) in previously untreated patients (pts) with advanced gastrointestinal malignancies.

Abstract Poster

Authors

null

Manish Sharma

The University of Chicago Medicine, Chicago, IL

Manish Sharma , Daniel V.T. Catenacci , Theodore Karrison , Anubha Ganjoo , Kenisha Allen , Grace K. Suh , Brooke Elizabeth Phillips , Robert de Wilton Marsh , Mark Kozloff , Blase N. Polite , Hedy L. Kindler

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01643499

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 427)

DOI

10.1200/JCO.2017.35.4_suppl.427

Abstract #

427

Poster Bd #

K11

Abstract Disclosures

Similar Posters

First Author: Manish Sharma

First Author: Smita Suhas Joshi

Poster

2017 Gastrointestinal Cancers Symposium

A single arm, prospective multicenter phase II study FOLFIRINOX in patients with advanced and recurrent biliary tract cancer.

A single arm, prospective multicenter phase II study FOLFIRINOX in patients with advanced and recurrent biliary tract cancer.

First Author: Naminatsu Takahara

First Author: Kouichirou Miyashita